Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Non-Tech : Le coin des francophones -- Ignore unavailable to you. Want to Upgrade?

To: Tom who wrote (13223)	2/22/2000 10:13:00 AM
From: buenojac	Respond to of 77509

Michel et TBoisvert: Merci, j'ai imprim‚ vos communiqu‚s pour r‚f‚rence ult‚rieure. Buenojac

To: Tom who wrote (13223)	2/22/2000 3:50:00 PM
From: AriKirA	Read Replies (1) \| Respond to of 77509

Tom, Felicitations pour ta patience avec PYT... Des profits de 50% tres bientot On vient de briser un point de resistance tres important. Malheureusement je n'ai plus de trader, mais j'ai toujours mes 2K long terme. C'est le risque que je prends ... 4 d'ici pas longtemps ! Pyng Technologies Corp - Pyng to appoint Dr. Charles Pollack to board Pyng Technologies Corp PYT Shares issued 9,921,922 2000-02-21 close $2.8 Tuesday Feb 22 2000 Mr. Michael Jacobs reports Dr. Charles V. Pollack Jr., MA, MD, FACEP, has placed his name forward for board membership with Pyng Technologies. Dr. Pollack is the chairman of the department of emergency medicine at Arizona Heart Hospital and Maricopa Medical Centre, Phoenix, Ariz. He also serves as chairman of the national research committee of the American College of Emergency Physicians. Dr. Pollack's extensive emergency medical background will be very valuable to the board, as his curriculum vitae and biosketch attest. Dr. Pollack has been a very strong supporter of the F.A.S.T.1 system for adult intraosseous infusion, which was researched, developed, and produced by Pyng Medical Corp., a subsidiary of Pyng Technologies. Pyng Technologies Corp. is expected to confirm expansion of its board to four members at its annual general meeting, to be held on Feb. 23, 2000. The addition of Dr. Pollack as a new board member of Pyng Technologies Corp. is fully supported by the board, and is indicative of the corporate changes that the company intends to put in place over the next few weeks. Pyng will implement a number of changes to reflect its shift from research and development to a profit-orientated full manufacturer of emergency medical devices. Summary biosketch Dr. Pollack, a native of central Alabama, earned his bachelor's degrees in chemistry and history and his MA degree in the history of science and medicine from Emory University in 1980. He graduated summa cum laude and was elected to both Phi Beta Kappa and Emory's Stipe Society of Scholars. He then attended Tulane University School of Medicine, graduated in the top 5 per cent of his class, and was elected to the Alpha Omega Alpha Medical Honorary Society. At graduation, he received both the Tulane Medical Alumni Association Award and the Creech Award for scholarship in surgery. After attending Tulane on a military scholarship. Dr. Pollack completed a surgical internship at U.S. Naval Hospital, San Diego, Calif. He then spent two years as a general medical officer with the Marine Corps and two years as an attending physician in the emergency department at Naval Hospital, San Diego, prior to serving his emergency medicine residency at the University of Mississippi Medical Centre in Jackson. In 1992, Dr. Pollack became attending physician and associate research director in the department of emergency medicine at Maricopa Medical Centre in Phoenix, an urban, tertiary care teaching hospital affiliated with the Medical College of the University of Arizona and the Mayo Graduate School of Medicine. In 1994, he became research director and associate residency director, and in 1997 he became department chairman at Maricopa. He is currently clinical associate professor of surgery (emergency medicine) at the University of Arizona. Dr. Pollack has been active in teaching and clinical research and is a national leader in emergency medicine. He is chairman of the national research committee of the American College of Emergency Physicians (ACEP) and has chaired and served on multiple other committees and task forces for ACEP and for the Society for Academic Emergency Medicine. He is the only physician to have received ACEP's highest national awards in both teaching and research; he also received the national teaching award from the council of emergency medicine residency directors. He is a founding editor of Journal Watch -- Emergency Medicine and is on the editorial boards of Journal of Emergency Medicine, emed.org, and emedicine.com. He is the international editor of the Hong Kong Journal of Emergency Medicine. He has written more than 150 original research articles, chapters, and abstracts, and lectures internationally on many varied topics in emergency medicine. He serves on the steering committees of five national grants and has received NIH, CDC, AHCPR, and industry financing for his own research. He has recently become the principal investigator of three new multicentre clinical research trials based in emergency departments nationwide. Dr. Pollack also served as medical director of the Medical Call Centre for National Health Enhancement Systems (later HBOC/NHES) in Phoenix between 1997 and 1999, and during that time developed additional experience and expertise in demand and disease management. He sits on the board of directors of the Emergency Medicine Foundation in Dallas, Tex. He is married and lives in Phoenix with his wife and three children. WARNING: The company relies upon litigation protection for "forward-looking" statements. (c) Copyright 2000 Canjex Publishing Ltd. canada-stockwatch.com old url (better for printing)